Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Approved medications include Saxenda, Victoza, Ozempic and Wegovy
Objectives This study used operant drug discrimination in male and female rats to assess how acute and repeated semaglutide treatment affects alcohols discriminative stimulus (interoceptive) effects
Concerns over counterfeit GLP-1 medicines The survey also highlighted concerns about the potential growth of the illicit market for weight loss medicines
Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle
